-
Posted by
Two Blokes Jun 27 -
Filed in
Stock
-
4 views
INmune Bio is working on a drug for Alzheimer's, with a critical phase 2 readout to be announced. It is unclear whether this will be positive or negative. Other potential drug candidates could help pick up the slack if MINDFuL is a dud.
